New pain pill enters first human safety tests
NCT ID NCT07618247
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial will test the safety and tolerability of a new experimental drug called IG001119 in 64 healthy volunteers. Participants will receive either the drug or a placebo tablet. The study aims to understand how the drug behaves in the body and identify any side effects, but it does not test whether the drug actually relieves pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
IG001119 (oral tablet)
What this could lead to
If safe and well-tolerated, this could pave the way for a new pain treatment option.
What could go wrong
This is a very early Phase 1 trial in healthy people, not patients with pain. It only tests safety and dosing, not whether the drug actually works for pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX
Adelaide, South Australia, Australia, 5000, Australia
Contact